Date: 2012-04-17
Type of information: Collaboration agreement
Compound: analytical services
Company: Labor L+S (Germany) Symbiosis, newly created unit of BioPharm (Germany)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: Labor L+S and SYMBIOSIS, the newly created business division of BIOPHARM GmbH have entered into an exclusive business alliance. As of May 1st, 2012 Labor L+S will be able to offer to its customers comprehensive services and solutions in analytical testing of biopharmaceuticals and classical pharmaceuticals exclusively performed by SYMBIOSIS. The business alliance with SYMBIOSIS expands the portfolio of Labor L+S and will enable clients of Labor L+S to order additional analytical services through a single point of contact, supporting all stages of the drug development life cycle and ensuring highest quality and improved cost and time efficiency for the benefit of its customers.
Financial terms:
Latest news:
